- Home
- EVAX vs APDN Comparison
EVAX vs APDN Comparison
Compare EVAX & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- APDN
- Stock Information
- Founded
- EVAX 2008
- APDN 1983
- Country
- EVAX Denmark
- APDN United States
- Employees
- EVAX N/A
- APDN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- APDN Other Consumer Services
- Sector
- EVAX Health Care
- APDN Consumer Discretionary
- Exchange
- EVAX Nasdaq
- APDN Nasdaq
- Market Cap
- EVAX 16.3M
- APDN 9.4M
- IPO Year
- EVAX 2021
- APDN N/A
- Fundamental
- Price
- EVAX $1.79
- APDN $0.05
- Analyst Decision
- EVAX Strong Buy
- APDN Strong Buy
- Analyst Count
- EVAX 3
- APDN 1
- Target Price
- EVAX $33.33
- APDN $1.50
- AVG Volume (30 Days)
- EVAX 211.9K
- APDN 4.2M
- Earning Date
- EVAX 03-26-2025
- APDN 02-13-2025
- Dividend Yield
- EVAX N/A
- APDN N/A
- EPS Growth
- EVAX N/A
- APDN N/A
- EPS
- EVAX N/A
- APDN N/A
- Revenue
- EVAX $3,295,000.00
- APDN $3,736,873.00
- Revenue This Year
- EVAX $9,039.73
- APDN $29.07
- Revenue Next Year
- EVAX $1.47
- APDN $70.38
- P/E Ratio
- EVAX N/A
- APDN N/A
- Revenue Growth
- EVAX N/A
- APDN N/A
- 52 Week Low
- EVAX $1.70
- APDN $0.05
- 52 Week High
- EVAX $22.05
- APDN $10.75
- Technical
- Relative Strength Index (RSI)
- EVAX 35.07
- APDN 18.82
- Support Level
- EVAX $1.75
- APDN $0.13
- Resistance Level
- EVAX $1.99
- APDN $0.15
- Average True Range (ATR)
- EVAX 0.17
- APDN 0.01
- MACD
- EVAX 0.05
- APDN -0.01
- Stochastic Oscillator
- EVAX 10.70
- APDN 2.20
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.